Table 4.

Clinical characteristics and outcomes between patients with and without CE within 7–12 days after symptom onset

	With CE (n = 9)	Without CE (n = 10)	P value
Age, years	50.8 ± 11.8	50.9 ± 12.0	0.982
Hematoma volume, mL	13.7 ± 9.5	14.1 ± 5.3	0.905
Current smoker, n (%)	5 (55.6)	6 (60.0)	0.605
Current alcohol use, n (%)	4 (44.4)	3 (30.0)	0.650
Systolic blood pressure, mm Hg	187.6 ± 30.0	144.3 ± 25.5	0.066
Diastolic blood pressure, mm Hg	104.0 ± 19.1	102.1 ± 16.9	0.821
Admission
NIHSS	10 (3–16)	8 (5–12)	0.495
GCS	15 (13–15)	15 (13–15)	0.740
30-day follow-up
NIHSS	4 (1–9)	2 (0–2)	0.049
BI	65 (43–100)	100 (90–100)	0.033
mRS 3–6, n (%)	6 (66.7)	1 (10.0)	0.020
90-day follow-up
NIHSS	3 (1–6)	1 (0–1)	0.024
BI	85 (68–95)	100 (100–100)	0.004
mRS 3–6, n (%)	3 (33.3)	1 (10.0)	0.303

Data are expressed as n (%), mean ± SD, or median (IQR) as appropriate

BI, Barthel Index, CE Cytotoxic edema, GCS Glasgow coma scale, IQR Interquartile range, mRS modified Rankin Scale, NIHSS National institutes of health stroke scale